Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system

被引:8
|
作者
Barnes, T. A.
McDonald, J.
Rowbotham, D. J.
Duarte, T. L.
Lambert, D. G. [1 ]
机构
[1] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia,Pharmacol & Therapeut Grp, Leicester LE1 5WW, Leics, England
[2] Univ Leicester, Dept Hlth Sci, Div Anaesthesia, Leicester LE1 5WW, Leics, England
[3] Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England
关键词
nociceptin; orphanin FQ; orphanin FQ receptor; desensitisation; inducible expression; second messengers; quantitative PCR;
D O I
10.1007/s00210-007-0189-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pretreatment of the G-protein coupled nociceptin receptor (NOP) with nociceptin/orphaninFQ (N/OFQ) produces desensitisation. The influences of receptor expression and genomic effects are largely unknown. We have used an ecdysone-inducible NOP expression system in a CHO line (CHOINDhNOP) to examine the effects of N/OFQ pretreatment upon receptor density, GTP gamma[S-35] binding, cAMP formation and NOP-mRNA. CHOINDhNOP induced with 5 and 10 mu M PonasteroneA (PonA) for 20 h produced NOP densities (B (max)) of 194 and 473 fmol. mg-1 protein, respectively. This was accompanied by decreased NOP mRNA. The lower B (max) is typical of the central nervous system. Pretreatment with 1 mu M N/OFQ significantly (p < e0.05) reduced B (max) at 5 and 10 mu M PonA to 100 and 196 fmol. mg-1 protein, respectively. There was no change in binding affinity. Along with the reduction in B (max), potency and efficacy for N/OFQ-stimulated GTP gamma[S-35] binding were also reduced (5 mu M PonA: pEC(50)-control=8.55 +/- 0.06, pretreated=7.88 +/- 0.07; E (max)-control=3.52 +/- 0.43, pretreated=2.48 +/- 0.10; 10 mu M PonA: pEC(50)-control=8.41 +/- 0.18, pretreated=7.76 +/- 0.03; E (max)-control=5.07 +/- 0.17, pretreated=3.38 +/- 0.19). For inhibition of cAMP formation, there was a reduction in potency (5 mu M PonA: pEC(50)-control=9.78 +/- 0.08, pretreated=8.92 +/- 0.13; 10 mu M PonA: pEC(50)-control=9.99 +/- 0.07, pretreated=9.04 +/- 0.14), but there was no reduction in efficacy. In addition, there were 39 and 31% reductions in NOP mRNA at 5 and 10 mu M PonA, respectively, but these measurements were made following concurrent N/OFQ challenge and PonA induction. In CHOINDhNOP, we have shown a reduction in cell surface receptor numbers and a reduction in functional coupling after N/OFQ pretreatment. This was observed at pseudo-physiological and supraphysiological receptor densities. Moreover, we also report a reduction in NOP mRNA, but further studies are needed which include Cypulsing' PonA and desensitizing following wash-out.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 22 条
  • [1] Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system
    T. A. Barnes
    J. McDonald
    D. J. Rowbotham
    T. L. Duarte
    D. G. Lambert
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 376 : 217 - 225
  • [2] Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists
    Park, Jong Yung
    Chae, Suji
    Kim, Chang Seop
    Kim, Yoon Jae
    Yi, Hyun Joo
    Han, Eunjoo
    Joo, Youngshin
    Hong, Surim
    Yun, Jae Won
    Kim, Hyojung
    Shin, Kyung Ho
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2019, 23 (06) : 427 - 448
  • [3] Adenovirus-mediated inducible gene expression in vivo by a hybrid ecdysone receptor
    Hoppe, UC
    Marbán, E
    Johns, DC
    MOLECULAR THERAPY, 2000, 1 (02) : 159 - 164
  • [4] Ecdysone-based system for controlled inducible expression of metabotropic glutamate receptor subtypes 2, 5, and 8
    Downey, PM
    Lozza, G
    Petrò, R
    Diodato, E
    Foglia, C
    Bottazzoli, F
    Brusa, R
    Asquini, T
    Reggiani, A
    Grilli, M
    JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (08) : 841 - 848
  • [5] Nociceptin/orphanin FQ opioid peptide-receptor expression in pachyonychia congenita
    Pan, Baohan
    Schroeder, Wolfgang
    Jostock, Ruth
    Schwartz, Mary
    Rosson, Gedge
    Polydefkis, Michael
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 241 - 248
  • [6] Tight transcriptional regulation of foreign genes in insect cells using an ecdysone receptor-based inducible system
    Dai, XJ
    Willis, LG
    Palli, SR
    Theilmann, DA
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 42 (02) : 236 - 245
  • [7] Nutritional state influences Nociceptin/Orphanin FQ peptide receptor expression in the dorsal raphe nucleus
    Przydzial, Magdalena J.
    Garfield, Alastair S.
    Lam, Daniel D.
    Moore, Stephen P.
    Evans, Mark L.
    Heisler, Lora K.
    BEHAVIOURAL BRAIN RESEARCH, 2010, 206 (02) : 313 - 317
  • [8] MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands
    Bird, M. F.
    McDonald, J.
    Horley, B.
    O'Doherty, J. P.
    Fraser, B.
    Gibson, C. L.
    Guerrini, R.
    Calo, G.
    Lambert, D. G.
    PLOS ONE, 2022, 17 (01):
  • [9] Effects of Spinally Administered Bifunctional Nociceptin/Orphanin FQ Peptide Receptor/μ-Opioid Receptor Ligands in Mouse Models of Neuropathic and Inflammatory Pain
    Sukhtankar, Devki D.
    Zaveri, Nurulain T.
    Husbands, Stephen M.
    Ko, Mei-Chuan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (01) : 11 - 22
  • [10] Respiratory Effects of the Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist, Cebranopadol, in Healthy Human Volunteers
    Dahan, Albert
    Boom, Merel
    Sarton, Elise
    Hay, Justin
    Groeneveld, Geert Jan
    Neukirchen, Meike
    Bothmer, John
    Aarts, Leon
    Olofsen, Erik
    ANESTHESIOLOGY, 2017, 126 (04) : 697 - 707